Clinical trials: Atrial Fibrillation Catheter Ablation
Atrial Fibrillation
Artificial Intelligence Guided Patient Selection for Atrial Fibrillation Catheter Ablation: Randomized Clinical Trial (AI-PAFA Trial)
Atrial fibrillation (AF) is a major cardiovascular disease with a prevalence of 1.7% of the total population in Korea, associated with 25% of ischemic stroke and 30% of heart failure, and is a major cardiovascular disease that…
- Trial name
- NCT04997824
- Testing
- Artificial Intelligence-based atrial fibrillation catheter ablation, Medical Therapy
- Where
- South Korea
- Volunteers
- 1,000 people
- Sponsor
- Yonsei University
Pericardial Effusion
Impact of Colchicine Therapy on Arrhythmia Recurrence After Acute Pericardial Effusion
The effects colchicine administration for acute pericardial effusion after radiofrequency catheter ablation (RFCA) of atrial fibrillation on the recurrences of arrhythmia.
- Trial name
- NCT02260206
- Testing
- Colchicine
- Where
- South Korea
- Volunteers
- 20 people
- Sponsor
- Yong Seog Oh
Atrial Fibrillation
Atrial Fibrillation Ablation: Radiofrequency or Cryoablation?
The study aims to compare 3 techniques routinely used for paroxysmal atrial fibrillation ablation: radiofrequency catheter ablation without contact-force, radiofrequency catheter ablation with contact-force and cryoablation.
- Trial name
- ARCFA (NCT03774550)
- Where
- France
- Volunteers
- 206 people
- Sponsor
- Centre Hospitalier Régional Metz-Thionville
Persistent Atrial Fibrillation, Persistent Atrial Fibrillation Longstanding
Catheter Ablation of Advanced Forms of Atrial Fibrillation
The purpose of this study is to evaluate feasibility, safety, and efficacy of pulmonary vein isolation combined with posterior left atrial isolation and multiple linear lesions in both atria in patients with persistent and…
- Trial name
- ENDO MAZE (NCT07446244)
- Testing
- Endovascular ablation set mimicking cox maze 4 procedure.
- Where
- Slovenia
- Volunteers
- 50 people
- Sponsor
- University Medical Centre Ljubljana
Atrial Fibrillation
Safe Use of New Oral Anticoagulants in Ablation for Atrial Fibrillation
Use of new oral anticoagulants (NOAC) in patients before and after catheter based pulmonary vein isolation (PVI) is still controversial.
- Trial name
- NCT02569255
- Testing
- Pulmonary venous ostia isolation
- Volunteers
- 234 people
- Sponsor
- Private Hospital Heart Center Varde
Paroxysmal Atrial Fibrillation
Effect of Cavotricuspid Isthmus Ablation in Patients Without History of Typical Flutter During Ablation
It has been demonstrated that successful cavotricuspid isthmus ablation may be effective in preventing paroxysmal atrial fibrillation. However, the effectiveness of only isthmus ablation on atrial fibrillation itself is unclear.
- Trial name
- NCT02031705
- Testing
- cavotricuspid isthmus ablation, control group
- Where
- South Korea
- Volunteers
- 366 people
- Sponsor
- Yong Seog Oh
Atrial Fibrillation (AF)
Photoplethysmography (PPG) Algorithm with Smartwatch in Evaluation of Atrial Fibrillation Burden After Catheter Ablation
The purpose of this study is to evaluate the effectiveness of a smart electrocardiogram watch based on the PPG algorithm in monitoring the atrial fibrillation burden of patients after catheter ablation.
- Trial name
- Polaris-AFCA (NCT06842160)
- Testing
- intervention group
- Where
- China
- Volunteers
- 10,000 people
- Sponsor
- Beijing Anzhen Hospital
Atrial Fibrillation, Paroxysmal Atrial Fibrillation
High-Power, Short-Duration Ablation in Treatment of Patients With Atrial Fibrillation
Atrial fibrillation (AF) stands as the most common type of cardiac arrhythmia. The frequency of AF in the overall population is 1-2%, with the incidence rate increasing with age from 0.5% in the 40-50 years old to 5-15% in those…
- Conditions
- Atrial Fibrillation, Paroxysmal Atrial Fibrillation, Persistent Atrial Fibrillation
- Trial name
- HPSD (NCT06415149)
- Testing
- High power short duration ablation with 50 W, High power short duration ablation with 45 W
- Where
- Russia
- Volunteers
- 185 people
- Sponsor
- People's Friendship University of Russia
Atrial Fibrillation
Anticoagulation After RFCA
The anticoagulation therapy is needed when rhythm control strategy is applied in atrial fibrillation patients but adverse events such as major bleeding exist.
- Trial name
- Reducible (NCT03573037)
- Testing
- Oral anticoagulant
- Where
- South Korea
- Volunteers
- 246 people
- Sponsor
- Yong Seog Oh
Atrial Fibrillation
Simplified Pulmonary Vein Isolation Using singLe Catheter and IntraCardiac Echocardiography
Ablation for paroxysmal atrial fibrillation (PAF) by means of pulmonary vein isolation (PVI) is the principal method for the treatment of PAF.
- Trial name
- Simple-ICE (NCT04923009)
- Testing
- ICE visualization and map construction
- Where
- Poland
- Volunteers
- 90 people
- Sponsor
- Centre of Postgraduate Medical Education
Atrial Fibrillation
Left Atrial Mechanical Function Improvement After Atrial Fibrillation Catheter Ablation
The objective of the study was to estimate the efficacy of telmisartan and amlodipine combination on the restoration of left atrial mechanical function after atrial fibrillation catheter ablation.
- Trial name
- NCT02734355
- Testing
- Telmisartan 80 mg and amlodipine 5 mg
- Volunteers
- 64 people
- Sponsor
- Research Institute for Complex Problems of Cardiovascular Diseases, Russia
Atrial Fibrillation, Persistent, Blood Pressure
Effect of Blood Pressure on Cardiovascular Outcomes and Recurrence After Catheter Ablation in Patients With Atrial Fibrillation
Effect of blood pressure on cardiovascular outcomes and recurrence after catheter ablation in patients with atrial fibrillation
- Trial name
- AF BP (NCT06433336)
- Where
- China
- Volunteers
- 800 people
- Sponsor
- Lanzhou University Second Hospital
Atrial Fibrillation
QDOT Based PVI for Atrial Fibrillation Treatment - The peQasus Study
PeQasus is a worldwide, retrospective, multicenter analysis focusing on QDOT based PVI. Data of at least 300 patients with QDOT based PVI will be collected. All data will be evaluated after anonymization.
- Trial name
- peQasus (NCT05710822)
- Testing
- pulmonary vein isolation
- Volunteers
- 300 people
- Sponsor
- University of Luebeck
Cardiac Arrhythmia, Atrial Fibrillation
Advanced TecHnologies For SuccEssful AblatioN of AF in Clinical Practice
ATHENA is a prospective, multicenter, non-randomized post-market study. All patients will be treated according to the standard care followed by each center.
- Trial name
- ATHENA (NCT05617456)
- Testing
- AF ablation
- Where
- Italy
- Volunteers
- 4,100 people
- Sponsor
- Giulio Zucchelli
Atrial Fibrillation Ablation Using PENTARAY Catheter
Predictors of Atrial Fibrillation Recurrence After Ablation Using PENTARAY Catheter
CARTO represent a new way of 3D electroanaromic mapping for AF which has improved safety and success rate of AF ablation compared with other conventional methods of AF ablation as it provide accurate visualization of atrial…
- Trial name
- NCT05101980
- Volunteers
- 20 people
- Sponsor
- Assiut University
Atrial Fibrillation, Atrio-Oesophageal Fistula
PrOgnosis Following Esophageal FisTula FormaTion in Pts Undergoing CathetER Ablation for AF Study
Pulmonary vein isolation emerged as an effective and safe strategy to treat atrial fibrillation patients. Atrio-oesophageal fistula (AOF) represents a rare but devastating complication of AF ablation procedure.
- Conditions
- Atrial Fibrillation, Atrio-Oesophageal Fistula, PVI, Catheter Ablation
- Trial name
- POTTER (NCT05273645)
- Where
- Germany
- Volunteers
- 138 people
- Sponsor
- University of Luebeck
Persistent Atrial Fibrillation
A New Approach to Target the Substrates of Persistent Atrial Fibrillation: The Sequential Substrate Ablation Approach
This is a prospective randomized controlled trial that compares the conventional stepwise approach with a new sequential substrate ablation approach for persistent atrial fibrillation.
- Trial name
- NCT02654353
- Testing
- Ablation
- Where
- Germany
- Volunteers
- 100 people
- Sponsor
- Johannes Gutenberg University Mainz
Persistent Atrial Fibrillation
Effect of Catheter Ablation on Left Atrial Function in Persistent Atrial Fibrillation
A total of 106 patients with drug-refractory persistent atrial fibrillation, who are planned to undergo circumferential pulmonary vein isolation (CPVI), will be randomly allocated into two groups.
- Trial name
- NCT03443232
- Testing
- Cryoballoon ablation, Radiofrequency ablation
- Where
- China
- Volunteers
- 106 people
- Sponsor
- The Second Hospital of Hebei Medical University
Arrhythmia, Atrial Fibrillation
Arterial Embolism After Catheter Ablation of Atrial Fibrillation. ATRIAL FIBRILLATION
The EMBOL-AF is a multicenter, international, observational study designed as a retrospective registry that will investigate the characteristics of systemic arterial embolic events after treatment of atrial fibrillation by…
- Conditions
- Arrhythmia, Atrial Fibrillation, Ablation, Stroke, Acute
- Trial name
- EMBOL-AF (NCT06134739)
- Testing
- No intervention.
- Where
- Spain
- Volunteers
- 500 people
- Sponsor
- Hospital Universitario La Paz
Coagulation; Intravascular
Randomized Comparison of Continuous and Intermittent Heparin Infusion During Catheter Ablation of Atrial Fibrillation
Optimal anticoagulation using heparin with close attention to maintain therapeutic dosing during the procedure is important. Randomized comparison of continuous and intermittent heparin infusion during catheter ablation of Atrial…
- Trial name
- COHERE (NCT01935557)
- Testing
- Continuous heparin infusion, Intermittent heparin infusion
- Where
- South Korea
- Volunteers
- 296 people
- Sponsor
- Yong Seog Oh